Conversely, BRAF V600E mutations, while prevalent in classic papillary thyroid carcinoma (PTC), are rare or absent in NIFTP but may occur in FVPTC, particularly in infiltrative or aggressive subtypes [13]. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.